BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38856147)

  • 21. Retraction Note: MiR-221 inhibits proliferation of pancreatic cancer cells via down regulation of SOCS3.
    Xie J; Wen JT; Xue XJ; Zhang KP; Wang XZ; Cheng HH
    Eur Rev Med Pharmacol Sci; 2024 Mar; 28(5):1639. PubMed ID: 38497847
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retraction Note: MicroRNA-132 stimulates the growth and invasiveness of trophoblasts by targeting DAPK-1.
    Wang YP; Zhao P; Liu JY; Liu SM; Wang YX
    Eur Rev Med Pharmacol Sci; 2022 Jul; 26(13):4545. PubMed ID: 35856341
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retraction Note: The potential preventive role of a dietary supplement containing hydroxytyrosol in COVID-19: a multi-center study.
    Dhuli K; Micheletti C; Medori MC; Madeo G; Bonetti G; Donato K; Gaffuri F; Tartaglia GM; Michelini S; Fiorentino A; Cesarz D; Connelly ST; Capodicasa N; Bertelli M
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(8):3288. PubMed ID: 38708488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retraction Note: Circular RNA circ_0079593 promotes glioma development through regulating KPNA2 expression by sponging miR-499a-5p.
    Yang Z; Li C; Fan XY; Liu LJ
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(20):7317. PubMed ID: 36314300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retraction Note: Knockdown of long non-coding RNA LUCAT1 reverses high glucose-induced cardiomyocyte injury via targeting CYP11B2.
    Yin Y; Yang ZF; Li XH; Zhou LQ; Zhang YJ; Yang B
    Eur Rev Med Pharmacol Sci; 2022 Nov; 26(21):7732. PubMed ID: 36394719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Retraction Note: LncRNA UCA1 affects osteoblast proliferation and differentiation by regulating BMP-2 expression.
    Zhang RF; Liu JW; Yu SP; Sun D; Wang XH; Fu JS; Xie Z
    Eur Rev Med Pharmacol Sci; 2024 Jun; 28(11):3701. PubMed ID: 38884520
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retraction Note: Long non-coding RNA DLEU7-AS1 promotes the occurrence and development of colorectal cancer via Wnt/β-catenin pathway.
    Liu XB; Han C; Sun CZ
    Eur Rev Med Pharmacol Sci; 2024 Apr; 28(7):2630. PubMed ID: 38639498
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retraction Note: Study of liver toxicity and DNA damage due to exposure to the pesticide Mancozeb in an experimental animal model - A pilot model.
    Suarez Uribe ND; Pezzini MF; Dall'Agnol J; Marroni N; Benitez S; Benedetti D; Da Silva J; Cerski CT; Dallegrave E; Macedo S; de Oliveira SCWSEF; Joveleviths D
    Eur Rev Med Pharmacol Sci; 2023 Nov; 27(21):10156. PubMed ID: 37975340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Retraction Note: Effect of atorvastatin on pulmonary arterial hypertension in rats through PI3K/AKT signaling pathway.
    Wang YY; Cheng XD; Jiang H
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):7881. PubMed ID: 37750615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Retraction Note: The carcinogenic complex lncRNA FOXP4-AS1/EZH2/LSD1 accelerates proliferation, migration and invasion of gastric cancer.
    Chen RY; Ju Q; Feng LM; Yuan Q; Zhang L
    Eur Rev Med Pharmacol Sci; 2022 Aug; 26(15):5311. PubMed ID: 35993622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retraction Note: Combination therapy with metformin and IL-12 to inhibit the growth of hepatic carcinoma by promoting apoptosis and autophagy in HepG2-bearing mice.
    Jin Z; Jia BX; Tan LD; Chen QM; Liu YH
    Eur Rev Med Pharmacol Sci; 2022 Oct; 26(19):6892. PubMed ID: 36263565
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LncRNA TUG1 aggravates the progression of prostate cancer and predicts the poor prognosis.
    Xu T; Liu CL; Li T; Zhang YH; Zhao YH
    Eur Rev Med Pharmacol Sci; 2022 May; 26(9):3057. PubMed ID: 35587053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Retraction Note: The relationship of kinesiophobia with depression and anxiety in nursing homes.
    Yükselmiş Ö
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(23):11200. PubMed ID: 38095368
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long noncoding RNA SNHG14 acts as an oncogene in prostate cancer via targeting miR-613.
    Sun B; Ke KB; Liu DF; Wang Q; Li YN; Chen JH; Zhang JH
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10919. PubMed ID: 33215403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Retraction Note: Role of long non-coding RNA SNHG1 in occurrence and progression of ovarian carcinoma.
    Ge J; Wu XM; Yang XT; Gao JM; Wang F; Ye KF
    Eur Rev Med Pharmacol Sci; 2022 Sep; 26(17):6013. PubMed ID: 36111900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LncRNA PROX1-AS1 promotes proliferation, invasion, and migration in prostate cancer via targeting miR-647.
    Qian C; Liao CH; Tan BF; Chen YF; Dang BW; Chen JL; Liu CB
    Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):8628. PubMed ID: 32964947
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of Concern.
    Listed NA
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(2):445. PubMed ID: 38305629
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long non-coding RNA PVT1 regulates glioma proliferation, invasion, and aerobic glycolysis via miR-140-5p.
    Shao Y; Chen HT; Ma QR; Zhang YW; He YQ; Liu J
    Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8249. PubMed ID: 32894529
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Blocking VRK2 suppresses pulmonary adenocarcinoma progression via ERK1/2/AKT signal pathway by targeting miR-145-5p.
    Mu Y; Liu WJ; Bie LY; Mu XQ; Zhao YQ
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3933. PubMed ID: 34156669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. LncRNA DLEU1 accelerates the malignant progression of clear cell renal cell carcinoma via regulating miRNA-194-5p.
    He GZ; Yu SY; Zhou QP; Chen ML; Zhang YW; Zheng Y; Zhang ZB; Han ZY; Yu J
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):10920. PubMed ID: 33215404
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.